HYpertension in the Very Elderly Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14031168

Enrollment

2100

Registered

2001-11-18

Start date

2001-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System Hypertension

Interventions

Two treatment groups: 1. Placebo 2. Indapamide Sustained Release (SR) 1.5 mg plus perindopril 2 - 4 mg if required. Goal: diastolic blood pressure less than 80 mmHg with systolic pressure less than 1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. People 80 years old and above 2. Sustained systolic pressure 160 - 199 mmHg and diastolic (phase V) pressure 90 - 109 mmHg 3. No evidence of renal failure or co-morbidity requiring anti-hypertensive treatment

Exclusion criteria

Exclusion criteria: Does not comply with above inclusion criteria.

Design outcomes

Primary

Measure	Time frame
Stroke events (fatal and non-fatal).	—

Secondary

Measure	Time frame
1. Total mortality 2. Cardiovascular mortality 3. Cardiac mortality 4. Stroke mortality 5. Skeletal fracture	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026